プログラム委員会
-
Cecil J. Nick, MS FTOPRA, Vice President (Technical)
Parexel Consulting, United Kingdom -
Jim Roach, MD, FACP Chief Medical Officer
Pulmatrix, United States -
Mary Ellen Cosenza, PHD, MS, RAC President
MEC Regulatory & Toxicology Consulting, LLC, United States -
David Gaugh, RPH Senior Vice President for Sciences and Regulatory Affairs
Generic Pharmaceutical Association (GPhA), United States -
Richard M Lewis, PHD CEO
Access BIO, United States -
Sundar Ramanan, PHD Director, Global Biosimilars R&D Policy
Amgen Inc., United States -
Jian Wang, MD, PHD Division Manager, Clinical Review Division – Heamatology/Oncology
Health Canada, Canada -
Joerg Windisch, PHD Chief Science Officer
Sandoz Biopharmaceuticals, Austria -
Sumant Ramachandra, MD, PHD, MBA Chief Scientific Officer & Senior VP of R&D and Medical Regulatory Affairs
Hospira, Inc., United States
